drugset / Trial / NCT04558580

Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures

NCT04558580

Phase 3 Withdrawn University of South Alabama
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy and safety of Rufinamide in reducing seizure frequency in subjects with partial seizures not fully controlled despite treatment with 1 to 3 concomitant antiepileptic drugs.

Timeline

Start
2006-04
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rufinamide Small molecule

Indications